FDA Approves Jazz Pharma’s Zepzelca + Tecentriq Combo for ES-SCLC
DUBLIN, Oct. 2, 2025 – Jazz Pharmaceuticals plc (Nasdaq: JAZZ) announced today that the U.S. Food and Drug Administration...
Cancer Research
Advertisement
Oncolytics Prepares Registration Trial in First-Line Pancreatic Cancer
SAN DIEGO, Sept. 29, 2025 — Oncolytics Biotech® Inc. (NASDAQ: ONCY) today announced a key update on its plan...
Sanguine Enhances Cancer Research with Expanded Biospecimen Offerings
September 16, 2025 — San Diego, California Sanguine Biosciences has announced the expansion of its oncology biospecimen offerings through...
Silexion’s SIL204 Shows Preclinical Promise in Pancreatic Cancer
GRAND CAYMAN, Cayman Islands, Sept. 11, 2025 – Silexion Therapeutics Corp. (NASDAQ: SLXN), a clinical-stage biotechnology company developing RNA...
Nike’s Phil and Penny Knight, $2B gift to Oregon Health & Science University’s Knight Cancer Institute
Portland, Oregon – August 14, 2025 – In what marks the largest single donation ever made to a U.S....
Advertisement
